These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38630069)

  • 1. Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future: Retraction.
    Infect Microbes Dis; 2021 Mar; 3(1):49. PubMed ID: 38630069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction.
    Open Biomed Eng J; 2018; 12():91. PubMed ID: 37915339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: The Impact of Charlson Comorbidity Index on Mortality From SARS-CoV-2 Virus Infection.
    Ahmed J; Avendaño Capriles CA; Avendaño Capriles NM; Mehta SM; Khan N; Tariq S; Abbas R; Tousif S; Shamim K
    Cureus; 2022 Mar; 14(3):r53. PubMed ID: 35342672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.
    Hill A; Garratt A; Levi J; Falconer J; Ellis L; McCann K; Pilkington V; Qavi A; Wang J; Wentzel H
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac056. PubMed ID: 35146053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mimicking as Pulmonary Tuberculosis in an Inmate.
    Akbar H; Kahloon R; Akbar S; Kahloon A
    Cureus; 2021 Aug; 13(8):r34. PubMed ID: 34522558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era.
    Saini J; Kaur P; Malik N; Lakhawat SS; Sharma PK
    Microbiol Res; 2022 Dec; 265():127206. PubMed ID: 36162150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction notice to "Antimicrobial secondary metabolites from marine gastropod egg capsules and egg masses".
    Kaviarasan T; Siva SR; Yogamoorthi A
    Asian Pac J Trop Biomed; 2015 Feb; 5(2):168. PubMed ID: 25830940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction:
    Frontiers Editorial Office
    Front Chem; 2024; 12():1433677. PubMed ID: 38855064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction notice to "Electroactive peptide-based supramolecular polymers" [Materials Today Bio, Volume 10, March 2021, 100099].
    Garifullin R; Guler MO
    Mater Today Bio; 2022 Dec; 16():100443. PubMed ID: 36311162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trend in Antimicrobial Resistance of
    Infect Drug Resist; 2021; 14():4215-4216. PubMed ID: 34866917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction Notice.
    Health Serv Res Manag Epidemiol; 2024; 11():23333928231216699. PubMed ID: 38328416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction: Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2.
    Frontiers Editorial Office
    Front Med (Lausanne); 2022; 9():947016. PubMed ID: 35712099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retracted] Consecutive stimulation of HBsAg promotes the viability of the human B lymphoblastoid cell line IM‑9 through regulating the SIRT1‑NF‑κB pathway.
    Bo J; Wang X; Li J; Wang W; Zhang J
    Oncol Lett; 2023 Jun; 25(6):239. PubMed ID: 37153051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RETRACTION:  How blockchain-timestamped protocols could improve the trustworthiness of medical science.
    Irving G; Holden J
    F1000Res; 2017; 6():805. PubMed ID: 28649375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine Nanoparticles with Enhanced in vitro Bioavailability: Characterization and Antimicrobial Activity [Retraction].
    Drug Des Devel Ther; 2024; 18():257-258. PubMed ID: 38333898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction: Epitopes screening and vaccine molecular design of SADS-CoV based on immunoinformatics.
    Frontiers Editorial Office
    Front Vet Sci; 2023; 10():1342203. PubMed ID: 38105774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction: Production of Potent Antimicrobial Compounds from
    Frontiers Editorial Office
    Front Microbiol; 2018; 9():1681. PubMed ID: 30034387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction notice to 'What we have learnt from the SARS epdemics in mainland China?' .
    Cao W; Fang L; Xiao D
    Glob Health J; 2021 Mar; 5(1):e1. PubMed ID: 33996176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Activity of Silver Nanoparticles Encapsulated in Poly-
    Int J Nanomedicine; 2023; 18():1873-1874. PubMed ID: 37057187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction: Samaha et al. Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon.
    Samaha AA; Mouawia H; Fawaz M; Hassan H; Salami A; Bazzal AA; Saab HB; Al-Wakeel M; Alsaabi A; Chouman M; Moussawi MA; Ayoub H; Raad A; Hajjeh O; Eid AH; Raad H
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34751680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.